Alongside ongoing organizational adjustments in the company’s structure in line with its growth, the objective of the company’s management is to uphold its sustainable sales growth in excess of average growth rates in the in­vitro diagnostics industry while simultaneously improving the company’s profitability, safeguard­ ing its liquidity position at all times, and detecting and averting any risk of erroneous developments in good time.